394 related articles for article (PubMed ID: 9071474)
1. Consequences of vitamin D receptor regulation for the 1,25-dihydroxyvitamin D3-induced 24-hydroxylase activity in osteoblast-like cells: initiation of the C24-oxidation pathway.
Staal A; van den Bemd GJ; Birkenhäger JC; Pols HA; van Leeuwen JP
Bone; 1997 Mar; 20(3):237-43. PubMed ID: 9071474
[TBL] [Abstract][Full Text] [Related]
2. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone.
van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA
Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716
[TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta-induced dissociation between vitamin D receptor level and 1,25-dihydroxyvitamin D3 action in osteoblast-like cells.
Staal A; Birkenhäger JC; Pols HA; Buurman CJ; Vink-van Wijngaarden T; Kleinekoort WM; van den Bemd GJ; van Leeuwen JP
Bone Miner; 1994 Jul; 26(1):27-42. PubMed ID: 7950503
[TBL] [Abstract][Full Text] [Related]
5. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
6. Regulation of messenger ribonucleic acid expression of 1 alpha,25-dihydroxyvitamin D3-24-hydroxylase in rat osteoblasts.
Nishimura A; Shinki T; Jin CH; Ohyama Y; Noshiro M; Okuda K; Suda T
Endocrinology; 1994 Apr; 134(4):1794-9. PubMed ID: 8137744
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of 1,25-dihydroxyvitamin D3 and EB 1089 on mouse renal and intestinal 25-hydroxyvitamin D3-24-hydroxylase.
Roy S; Martel J; Tenenhouse HS
J Bone Miner Res; 1995 Dec; 10(12):1951-9. PubMed ID: 8619376
[TBL] [Abstract][Full Text] [Related]
8. The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses.
Chen TL; Hauschka PV; Cabrales S; Feldman D
Endocrinology; 1986 Jan; 118(1):250-9. PubMed ID: 3000737
[TBL] [Abstract][Full Text] [Related]
9. Effects of 'non-calcaemic' vitamin D analogues on 24-hydroxylase expression in MG-63 osteoblast-like cells.
Schroeder NJ; Burrin JM; Noonan K; Makin HL; Cunningham J
Nephron Physiol; 2003; 94(4):p62-73. PubMed ID: 12972708
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium.
Healy KD; Zella JB; Prahl JM; DeLuca HF
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9733-7. PubMed ID: 12900504
[TBL] [Abstract][Full Text] [Related]
11. Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors.
Chen J; Dosier CR; Park JH; De S; Guldberg RE; Boyan BD; Schwartz Z
J Tissue Eng Regen Med; 2016 Jan; 10(1):40-51. PubMed ID: 23784946
[TBL] [Abstract][Full Text] [Related]
12. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone enhances vitamin D-24-hydroxylase expression in osteoblastic (UMR-106) and renal (LLC-PK1) cells treated with 1alpha,25-dihydroxyvitamin D3.
Kurahashi I; Matsunuma A; Kawane T; Abe M; Horiuchi N
Endocrine; 2002 Mar; 17(2):109-18. PubMed ID: 12041912
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone increases 1,25-dihydroxyvitamin D3 receptor levels and augments bioresponses in rat osteoblast-like cells.
Chen TL; Hauschka PV; Feldman D
Endocrinology; 1986 Mar; 118(3):1119-26. PubMed ID: 3004896
[TBL] [Abstract][Full Text] [Related]
15. The effects of MC903 on 1,25-(OH)2D3 receptor binding, 24-hydroxylase activity and in vitro bone resorption.
Pols HA; Birkenhäger JC; Schilte JP; Bos MP; van Leeuwen JP
Bone Miner; 1991 Aug; 14(2):103-11. PubMed ID: 1655130
[TBL] [Abstract][Full Text] [Related]
16. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
Ellison TI; Eckert RL; MacDonald PN
J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
[TBL] [Abstract][Full Text] [Related]
17. Hormonal responses to 1,25-dihydroxyvitamin D3 in cultured mouse osteoblast-like cells--modulation by changes in receptor level.
Chen TL; Li JM; Ye TV; Cone CM; Feldman D
J Cell Physiol; 1986 Jan; 126(1):21-8. PubMed ID: 3003120
[TBL] [Abstract][Full Text] [Related]
18. Osteoblast differentiation and control by vitamin D and vitamin D metabolites.
van Driel M; Pols HA; van Leeuwen JP
Curr Pharm Des; 2004; 10(21):2535-55. PubMed ID: 15320744
[TBL] [Abstract][Full Text] [Related]
19. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
Kaufmann M; Lee SM; Pike JW; Jones G
Endocrinology; 2015 Dec; 156(12):4388-97. PubMed ID: 26441239
[TBL] [Abstract][Full Text] [Related]
20. Regulation of intestinal vitamin D receptor expression in experimental uraemia: effects of parathyroidectomy and administration of PTH.
Szabó A; Schmutz A; Pesian S; Schmidt-Gayk H; Ritz E; Reichel H
Nephrol Dial Transplant; 1998 Feb; 13(2):340-9. PubMed ID: 9509444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]